Showing results (211-220 of 322) with videos related to
Sort By:
Pageof 33
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Rejection prophylaxis with sequential OKT3 and CSA after kidney transplantationW Weimar, C J Hesse, L M Vaessen, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1992
MTP-PE in liposomes as a biological response modifier in the treatment of cancer: current statusH FrostBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Clinical trials of bestatin for leukemia and solid tumorsK Ota, Y UzukaBiotherapy (Dordrecht, Netherlands)|January 1, 1991
Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropeniaK Hirashima, Y Yoshida, S Asano, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Pharmacokinetic requirements for successful site-directed targeting of drugsC McMartinBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Systemic IL-1 and adjuvant treatment of an experimental tumor. I. Immune status following tumor rechallengeR L Hornung, S M Kiertscher, H L MathewsBiotherapy (Dordrecht, Netherlands)|January 1, 1992
Endolymphatic delivery of IL2 in patients with melanoma and lymphomaD W Galvani, S Walton, J M Davies, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
Intrapleural application of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer. A multi-institutional cooperative studyK Yasumoto, T OguraBiotherapy (Dordrecht, Netherlands)|January 1, 1991
Growth inhibitory effect of bestatin on choriocarcinoma cell lines in vitroK Ino, S Goto, A Kosaki, et al.Biotherapy (Dordrecht, Netherlands)|January 1, 1991
The augmentative effect of a protein-bound polysaccharide (PSK) on tumoricidal activity of the soluble factor produced by a streptococcal preparation (OK-432)-activated macrophagesN Baba, H Kawami, Y Sato, et al.Pageof 33